SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000118
Filing Date
2010-02-03
Accepted
2010-02-03 16:37:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO THE SCHEDULE 13G sc13ga607422aeo_12312009.htm SC 13G/A 238303
2 JOINT FILING AGREEMENT ex991to13ga607422aeo_123109.htm EX-99.1 31195
  Complete submission text file 0000921895-10-000118.txt   271670
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Subject) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-79369 | Film No.: 10571142
SIC: 2834 Pharmaceutical Preparations